Several decades of research of glioma has shown that not only does TP53 serve a central role in the regulatory network of tumorigenesis, but also that the TP53 status is closely associated with the disease progression and survival of patients with GBM during radio- and chemotherapy9,10. The gene discussed is TP53; the disease is glioblastoma.